Relevant bibliographies by topics / Biocybernetic diagnostics and therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Biocybernetic diagnostics and therapy'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Biocybernetic diagnostics and therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Biocybernetic diagnostics and therapy"

1

Reinhard Fuhr, Dr. phil., Martina Gremmler-Fuhr, M.A., and Milan Sreckovic, Ph.D. "Diagnostics in Gestalt Therapy." Gestalt Review 4, no. 3 (2000): 237. http://dx.doi.org/10.5325/gestaltreview.4.3.0237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Maksimova, E. V., and I. L. Kliaritskaia. "Hepatic encephalopathy, diagnostics, differential diagnostics and therapy with ornithine." Consilium Medicum 20, no. 12 (2018): 110–16. http://dx.doi.org/10.26442/20751753.2018.12.000019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Witasek, A. "FX Mayr diagnostics and therapy." Focus on Alternative and Complementary Therapies 8, no. 4 (June 14, 2010): 556–57. http://dx.doi.org/10.1111/j.2042-7166.2003.tb04101.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Noakes, P., and P. Byrne. "Informatics – electronic diagnostics and therapy." Die Psychiatrie 07, no. 02 (April 2010): 100–106. http://dx.doi.org/10.1055/s-0038-1669594.

Full text
Abstract:
SummaryMental health professionals did not ask for it, but the proliferation of health informatics and the integration of connectivity into our daily lives will facilitate and improve mental health outcomes – provided change is clinician-driven. To date, no one informatics system achieved dominance and there is no consensus about how to proceed. Key systems’ components are identified. There are multiple technical, clinical, ethical and financial considerations that have delayed the routine use of these systems even in highly developed health services. Several interacting systems are discussed across general medical and mental health services. Informatics can assist with the diagnosis of some mental health conditions (anxiety, mood and substance misuse disorders), and a balance needs to be struck between excessive self-diagnoses and empowered patients. Allied systems, for example telemedicine, can assist clinicians in physical and many mental health disorders, but less so, severe enduring mental illness. Computerised therapies have a growing evidence base but may not suit every patient and all disorders. Once electronic databases are established across psychiatry, they will be used outside the clinical arena to pursue diverse research and economic agendae, with other uses as yet undefined. We conclude by speculating on possible future developments.
APA, Harvard, Vancouver, ISO, and other styles
5

Haberlová, Jana, Alžběta Slabá, Petra Hedvičáková, and Tereza Doušová. "Spinal muscular atrophy - diagnostics, therapy, research." Neurologie pro praxi 17, no. 6 (December 1, 2016): 349–53. http://dx.doi.org/10.36290/neu.2016.073.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Novosad, Jakub, and Irena Krčmová. "Bronchial asthma diagnostics and therapy highlights." Interní medicína pro praxi 20, no. 1 (March 1, 2018): 14–18. http://dx.doi.org/10.36290/int.2018.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Polz-Dacewicz, Małgorzata. "Cytomegalovirus – epidemiology, diagnostics, therapy and prophylaxis." Forum Zakażeń 4, no. 1 (April 2, 2013): 36–40. http://dx.doi.org/10.15374/fz2013008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shabalin, V. V., and Yu I. Grinshteyn. "Cardiac sarcoidosis: modern diagnostics and therapy." Russian Journal of Cardiology 25, no. 11 (December 5, 2020): 4052. http://dx.doi.org/10.15829/29/1560-4071-2020-4052.

Full text
Abstract:
Cardiac sarcoidosis (CS) is a potentially life-threatening granulomatous heart disease with unclear etiology and a suspected pathological immune response to an unidentified antigenic trigger in individuals with a genetic predisposition. CS often occurs as a part of systemic sarcoidosis, but in rare cases it can be isolated. The latter phenotype is especially difficult to diagnose, since it requires a differential diagnosis with a number of other myocardial diseases. Depending on the location and area, the clinical performance can vary from asymptomatic to severe cardiac manifestations — decompensated heart failure, malignant arrhythmias and conduction disorders, as well as sudden death. Methods for diagnosing CS are constantly being improved. In the presented review, the emphasis is on modern methods, diagnostic criteria, and approaches to the therapy of CS.
APA, Harvard, Vancouver, ISO, and other styles
9

Eremeeva, K. V. "Mycoses in otorhinolaryngology: diagnostics, prevention, therapy." Medical Council, no. 18 (January 1, 2016): 14–17. http://dx.doi.org/10.21518/2079-701x-2016-18-14-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Laczi, Ferenc. "Etiology, diagnostics and therapy of hyponatremias." Orvosi Hetilap 149, no. 29 (July 1, 2008): 1347–54. http://dx.doi.org/10.1556/oh.2008.28409.

Full text
Abstract:
A tanulmány klinikusok számára foglalja össze a hyponatraemiák kóroktanát, diagnosztikáját és kezelését. A hyponatraemia a leggyakoribb elektrolit-rendellenesség. Az enyhe és mérsékelt fokú hyponatraemia a hospitalizált betegek 15–30%-ában, súlyosabb formája azok 1–4%-ában fordul elő. Patofiziológiai szempontból a hyponatraemiák két fő csoportja különböztethető meg: nem ozmotikus eredetű hypervasopressinaemiás hyponatraemiák (hypovolaemiás, hypervolaemiás, euvolaemiás) és nem hypervasopressinaemiás hyponatraemiák (pseudohyponatraemia, vízmérgezés, cerebrális sóvesztő szindróma). Az enyhe hyponatraemiás betegek sokszor tünetmentesek. A súlyos hyponatraemia az életet veszélyeztető központi idegrendszeri tüneteket okozhat. A hyponatraemiás állapotok kórismézése során figyelemmel vagyunk az extracelluláris folyadék térfogatára, a klinikai tünetekre, a hyponatraemia súlyosságára, kifejlődésének sebességére és tartamára. A hyponatraemia okainak felderítésekor az első feladat a nem hypervasopressinaemiás hyponatraemiák és a hypervasopressinaemiás hyponatraemiák elkülönítése a plazma ozmolalitásának, a vércukornak, a szérumlipidek és -fehérjék szintjének mérésével. A további differenciáldiagnosztikus ténykedést a vizelet ozmolalitásának, az extracelluláris folyadék térfogatának és a vizelet nátriumkoncentrációjának meghatározása segíti. Az euvolaemiás hyponatraemiák legfontosabb megjelenési formája a SIADH. A SIADH diagnózisát az egyéb kórismék kizárása biztosítja; itt kulcsadat, hogy a csökkent plazmaozmolalitáshoz (<275 mosmol/ttkg) viszonyítva a vizelet ozmolalitása (>100 mosmol/ttkg) aránytalanul nagy. Az akut (<48 óra), súlyos hyponatraemia (<120 mmol/l) intenzív terápiát igényel a normális ozmotikus viszonyok gyors helyreállításával. (A szérum nátriumemelkedésének sebessége óránként 1 mmol/l.) A krónikus (>48 óra), szimptómás hyponatraemia kezelése során a szérum nátriumszintjének gyors emelkedése demyelinisatiós szindrómát okozhat. (A szérum nátriumemelkedésének sebessége ne haladja meg az óránkénti 0,5 mmol/l-t!) A krónikus aszimptómás hyponatraemia (a hypovolaemia kivételével) kezelésében a hagyományos eljárásokat (folyadékbevitel-korlátozás, demeclocyclin, lítium, urea, furosemid + sóbevitel) a közeli jövőben a vazopresszinreceptor-antagonisták alkalmazása válthatja fel. A 2-es típusú vazopresszinreceptor-antagonista lixivaptan, tolvaptan és satavaptan, továbbá az 1A+2 típusú vazopresszinreceptor-antagonista conivaptan elektrolitvesztés nélkül növeli a vese vízkiválasztását és emeli a szérum nátriumszintjét.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Biocybernetic diagnostics and therapy"

1

Smit, Jan Gerhard. "Grundlagen der wissenschaftlichen Biokybernetischen Diagnostik und Therapie für funktionell chronisch Kranke." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2010. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-62518.

Full text
Abstract:
Das Buch enthält eine Reihe grundlegender Artikel zur Biokybernetischen Diagnostik und Therapie aus Vorträgen, Seminaren usw. Das Verfahren der ganzheitlichen „Biokybernetischen Diagnostik und Therapie“ geht weit über die Akupunktur hinaus. Sie ist keine Alternativmedizin, sondern für austherapierte funktionelle Kranke.
APA, Harvard, Vancouver, ISO, and other styles
2

Smit, Jan Gerhard. "Grundlagen der Kybernetischen Medizin (Reflexmedizin) mit Mikropressur und dem Reflexotron." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2010. http://nbn-resolving.de/urn:nbn:de:swb:14-opus-23441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ehtaiba, Mabrouka Haiba. "Use of microwave techniques in medical diagnostics and therapy." Thesis, Cardiff University, 2017. http://orca.cf.ac.uk/103482/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brennecke, Johannes. "Molecular diagnostics of the bacterial response to antibiotic therapy." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28843.

Full text
Abstract:
Bacterial bloodstream infections (BSIs) are a major healthcare problem causing high mortality and economic cost. BSIs require an immediate initiation of antibiotic therapy as any delay is associated with a mortality increase. With the emergence of antimicrobial resistance, the choice of the appropriate antibiotic becomes increasingly difficult, thus creating an urgent need for new diagnostics, ideally to be done at the point of care. The current gold standard is blood culture with subsequent susceptibility testing although several molecular methods have recently entered the market. However, in many instances there is a discrepancy between the in-vitro data provided by the test and the outcome of antimicrobial therapy in-vivo because current diagnostics fail to take into account the impact of the environment in the patient such as the immune system, pharmacokinetics and pharmacodynamics or bacterial fitness. In this thesis, it was hypothesised that the measurement of the bacterial gene expression after the beginning of antibiotic therapy might be a more accurate indicator of the therapy outcome because it reflects the bacterial response under in-vivo conditions. In the first part of the thesis the expression of a set of pre-defined mRNA markers was investigated under various conditions. Experiments conducted with clinical E. coli isolates incubated in human whole blood revealed an excellent correlation between the gene expression, the treatment outcome, the antibiotic susceptibility and the genetic background for three different classes of antimicrobial drugs. The second part of the thesis describes the extraction of bacterial RNA from human whole blood specimen. The effect of different agents for the lysis of human blood cells and the impact of co-purified human RNA were analysed and a method for high yield extraction of undegraded bacterial RNA was established. The third part of the thesis investigates two methods for the sensitive measurement of the bacterial gene expression. This is relevant because the bacterial loads in BSI patients are extremely low. For genes with high gene expression levels both methods yielded reliable results but were unable to quantify the expression of the previously investigated mRNA markers due to their low copy numbers. Other approaches, especially those based on single cell measurements, might be able to overcome the problem in the future and should be explored in greater detail. Overall, the foundations for a future diagnostic test based on the measurement of the bacterial gene expression have been laid in this work. Future work should address the mRNA quantification and further evaluate the connection between gene expression and therapy outcome, e.g. in animal models. A future diagnostic test should also fulfil point-of-care requirements. This will include integrated sample preparation and quantification as well as a time-to-result in the range of a few minutes.
APA, Harvard, Vancouver, ISO, and other styles
5

Conde, João Diogo Osório de Castro. "Cancer theranostics: multifunctional gold nanoparticles for diagnostics and therapy." Doctoral thesis, Faculdade de Ciências e Tecnologia, 2013. http://hdl.handle.net/10362/10927.

Full text
Abstract:
Doctorate in Biology, Specialty in Biotechnology
The use of gold nanoparticles (AuNPs) has been gaining momentum in molecular diagnostics due to their unique physico-chemical properties these systems present huge advantages, such as increased sensitivity, reduced cost and potential for single-molecule characterisation. Because of their versatility and easy of functionalisation, multifunctional AuNPs have also been proposed as optimal delivery systems for therapy (nanovectors). Being able to produce such systems would mean the dawn of a new age in theranostics (diagnostics and therapy)driven by nanotechnology vehicles. Nanotechnology can be exploit for cancer theranostics via the development of diagnostics systems such as colorimetric and imunoassays, and in therapy approaches through gene therapy, drug delivery and tumour targeting systems. The unique characteristics of nanoparticles in the nanometre range, such as high surface-tovolume ratio or shape/size-dependent optical properties, are drastically different from those of their bulk materials and hold pledge in the clinical field for disease therapeutics This PhD project intends to optimise a gold-nanoparticle based technique for the detection of oncogenes’ transcripts (c-Myc and BCR-ABL) that can be used for the evaluation of the expression profile in cancer cells, while simultaneously developing an innovative platform of multifunctional gold nanoparticles (tumour markers, cell penetrating peptides, fluorescent dyes) loaded with siRNA capable of silencing the selected proto-oncogenes, which can be used to evaluate the level of expression and determine the efficiency of silencing. This work is a part of an ongoing collaboration between Research Centre for Human Molecular Genetics, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Portugal and Biofunctional Nanoparticles and Surfaces Group, Instituto de Nanociencia de Aragón, Spain within a European project [NanoScieE+ - NANOTRUCK]. In order to achieve this goal we developed effective conjugation strategies to combine, in a highly controlled way, biomolecules to the surface of AuNPs with specific functions such as: ssDNA oligos to detect specific sequences and for mRNA quantification; Biofunctional spacers: Poly(ethylene glycol) (PEG) spacers used to increase solubility and biocompatibility and confer chemical functionality; Cell penetrating peptides: to overcome the lipophilic barrier of the cellular membranes and deliver molecules into cells using TAT peptide to achieve cytoplasm and nucleus; Quaternary ammonium: to introduce stable positively charged in gold nanoparticles surface; and RNA interference: siRNA complementary to a master regulator gene, the proto-oncogene c-Myc, that is implicated in cell growth, proliferation, loss of differentiation, and cell death. In order to establish that they are viable alternatives to the available methods, these innovative nanoparticles were extensively characterized on their chemical functionalization, ease of uptake, cellular toxicity and inflammation, and knockdown of MYC protein expression in several cancer cell lines and in in vivo models.
Fundação para a Ciência e Tecnologia - (SFRH/BD/62957/2009); PTDC/BIO/66514/2006; NANOLIGHT-PTDC/QUI-QUI/112597/2009; Silencing the silencers via multifunctional gold nanoconjugates towards cancer therapy - PTDC/BBB-NAN/1812/2012
APA, Harvard, Vancouver, ISO, and other styles
6

Hobson, N. J. "Nanoparticle theranostics for applications in cancer diagnostics and cancer therapy." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1546610/.

Full text
Abstract:
Traditionally, medicine has been conducted using a diagnostic procedure followed by an appropriate therapy and monitored were possible. On the whole, these steps have happened independently of each other. In recent years however many have started to question this independent approach and have asked whether technologies that seek to combine diagnostics and therapies would be more beneficial at treating diseases. This new medical discipline has been termed theranostics. The aim of this project was to design and synthesise a novel theranostic nanoparticle, using a micelle forming amphiphilic carbohydrate, with the overall hypothesis of determining whether using a nanomedicine that can simultaneously image and treat would improve the effectiveness of a cancer treatment. Super paramagnetic iron oxide nanoparticles (IONPs) have gained considerable attention as an MRI contrast agent due to their unique magnetic properties and relatively inoffensive toxicity profile. Before IONPs may be used in a biological environment they must overcome several challenges, including being stable to aggregation and organ targeting. In this project a modified chitosan amphiphilic polymer was used to successfully formulate IONPs into colloidal stable aqueous dispersions using two different methods which produced blackberry nanoparticles and raspberry nanoparticles. The raspberry nanoparticles were extensively characterised in vitro and in vivo and were found to be highly effective as an MRI imaging probe for the liver and spleen. Following this, they were tested for their cancer imaging properties in an in vivo mouse tumour model. The drug loading capacity of the raspberry nanoparticles was investigated using lomustine, paclitaxel and methotrexate, however no effective drug encapsulation was determined in this project. Overall, a highly effective MRI probe was engineered and characterised, although its future success will be determined by its activity towards a disease target.
APA, Harvard, Vancouver, ISO, and other styles
7

Mohammad, Zadeh Maryam. "Towards high throughput mechanical testing of cells for diagnostics and therapy." Thesis, Heriot-Watt University, 2017. http://hdl.handle.net/10399/3345.

Full text
Abstract:
This thesis will focus on the modelling and quantification of the mechanical properties of biological samples with the aid of Atomic Force Microscopy (AFM). The importance of studying the mechanical properties of biological samples lies in its potential use for both therapeutic and diagnostic research as well as in bioengineering fields such as designing/selecting appropriate cell sorting and separation techniques. First part of this thesis is focused on developing a mathematical model by considering the physical properties (size and membrane thickness) of cells, to measure the size changes and Young’s elastic modulus of mammalian cells. Developed model showed promising results in measuring the changes in the radius of the cells after deformation. Also, it has been showed that there is a direct relation between the shape of the indenter and obtained elastic modulus. Moreover, the Young’s elastic modulus derived from fitting the developed model into force-indentation curves was in the range of MPa. This is due to measuring the elastic properties of cells on the surface elements (lipid bilayer). Producing manufactured red blood cells (RBCs) is increasing due to the high demand for blood transfusions and lack of eligible donors. Manufactured RBCs require continuous sorting and separation process during their production, as well as at the end of the manufacturing process, where reticulocytes are formed. Selecting appropriate sorting and separation methods, which are highly efficient and have the minimum drawback, is essential. Techniques which are carry out the cell separation processes based on the mechanical and physical properties of cells shows promising results. Therefore, the second part of this thesis was designed to measure the mechanical and physical properties of CD34+ stem cells during their expansion and differentiation processes (Days 11, 14, 18 and 21) for cell purification and separation purposes. Obtained results showed that size-based techniques can be applied to sort cells at day 11 of differentiation process from the day 14, while for sorting day 14 cells from day 18 and day 18 cells from day 21, any elasticity or sized based techniques cannot provide a highly purified/sorted culture and significant contaminations would be remained. In addition, the mechanical properties of the extruded nucleus from the CD34+ cells was also quantified for studying their effects on the elastic properties of the CD34+ cells. Derived results showed that to eliminate the free-floating nucleus form the culture media, elasticity and size-based techniques can be used and provide a high efficient sorted culture (100% separation).
APA, Harvard, Vancouver, ISO, and other styles
8

Sandberg, Carin. "Aspects of fluorescence diagnostics and photodynamic therapy in non-melanoma skin cancer /." Göteborg : Department of Dermatology and Venereology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy University, University of Gothenburg, 2009. http://hdl.handle.net/2077/21192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Persson, Mikael. "Antibody Mediated Radionuclide Targeting of HER-2 for Cancer Diagnostics and Therapy : Preclinical Studies." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6798.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nestor, Marika. "Antibody-Based Radionuclide Targeting for Diagnostics and Therapy : Preclinical Studies on Head and Neck Cancer." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7341.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Biocybernetic diagnostics and therapy"

1

Pawlikowski, M. Somatostatin analogs in diagnostics and therapy. Austin, Tex: Landes Bioscience, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Andreescu, Silvana. Oxidative stress: Diagnostics, prevention, and therapy. Edited by American Chemical Society. Division of Analytical Chemistry. Washington, DC: American Chemical Society, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Andreescu, Silvana, and Maria Hepel, eds. Oxidative Stress: Diagnostics, Prevention, and Therapy. Washington, DC: American Chemical Society, 2011. http://dx.doi.org/10.1021/bk-2011-1083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Frank, Natterer, ed. Computational Radiology and Imaging: Therapy and Diagnostics. New York, NY: Springer New York, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jelínková, Helena. Lasers for medical applications: Diagnostics, therapy, and surgery. Oxford: WP/Woodhead Publishing, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Peeling, W. B., and Hermann Becker, eds. Progress in Diagnostics and Therapy of Prostatic Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-79947-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hepel, Maria, and Silvana Andreescu, eds. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2. Washington, DC: American Chemical Society, 2015. http://dx.doi.org/10.1021/bk-2015-1200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nanomedicine: Basic and clinical applications in diagnostics and therapy. Basel: Karger, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hans-Dieter, Kuntz, and SpringerLink (Online service), eds. Hepatology Textbook and Atlas: History · Morphology Biochemistry · Diagnostics Clinic · Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1948, Kuntz Hans-Dieter né, ed. Hepatology: Principles and practice : history, morphology, biochemistry, diagnostics, clinic, therapy. Berlin: Springer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Biocybernetic diagnostics and therapy"

1

Noguchi, Emi. "Companion Diagnostics." In Molecular Targeted Therapy of Lung Cancer, 117–36. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2002-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meurer, Stefan, Reinhard Wallich, Manfred Volm, Walter Jens Zeller, Stefan Fruehauf, Bernhard K. Keppler, Wilfried Hefter, and Martin Berger. "Diagnostics and Experimental Therapy." In Current Cancer Research 1992, 103–18. Heidelberg: Steinkopff, 1992. http://dx.doi.org/10.1007/978-3-662-11384-4_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meuer, Stefan C., Dymitr Komitowski, Svetlana Karnaoukhova, Ralf Bracht, and Margot Zöller. "Diagnostics and Experimental Therapy." In Current Cancer Research 1995, 81–95. Heidelberg: Steinkopff, 1995. http://dx.doi.org/10.1007/978-3-642-48687-6_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Knopp, Michael V., Stefan Delorme, Antonia Dimitrakopolou-Strauss, Rita Engenhart, Jürgen Debus, Peter Huber, Peter Bachert, and Thomas Hess. "Radiological Diagnostics and Therapy." In Current Cancer Research 1995, 97–124. Heidelberg: Steinkopff, 1995. http://dx.doi.org/10.1007/978-3-642-48687-6_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

van Kaick, Gerhard, Dietrich von Fournier, Gerald Glombitza, Christian Herfarth, Wolfram Lamadé, Hans-Peter Meinzer, Barbara Bertram, et al. "Diagnostics and Experimental Therapy." In Current Cancer Research 1998, 89–118. Heidelberg: Steinkopff, 1998. http://dx.doi.org/10.1007/978-3-642-95995-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schlegel, Wolfgang, Jürgen Dams, Uwe Haberkorn, Uwe Engelmann, and Malte L. Bahner. "Radiological Diagnostics and Therapy." In Current Cancer Research 1998, 119–40. Heidelberg: Steinkopff, 1998. http://dx.doi.org/10.1007/978-3-642-95995-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jagadeesan, Vidya, Margaret Powers-Fletcher, and Kimberly E. Hanson. "Preemptive antifungal therapy: Do diagnostics help?" In Antifungal Therapy, 97–114. Second edition. | New York, NY : CRC Press, [2019]: CRC Press, 2019. http://dx.doi.org/10.1201/9780429402012-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Song, Sophie, and Faramarz Naeim. "New Applications of Flow Cytometry in Cancer Diagnosis and Therapy." In Cancer Diagnostics, 199–232. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-791-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sumazaki, Makoto, and Koji Ueda. "Liquid Biopsy Diagnostics Using Extracellular Vesicles." In Biomarkers in Cancer Therapy, 3–10. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7295-7_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kumar, Sumit, Pooja Kumari, Gaurav Rathee, and Brijesh Rathi. "Nanomaterials for Early Cancer Diagnostics." In Nanomedicine for Cancer Diagnosis and Therapy, 97–114. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-7564-8_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Biocybernetic diagnostics and therapy"

1

Plontke, S., S. Kösling, N. Pazaitis, P. Caye-Thomasen, and T. Rahne. "Diagnostics and Therapy for intralabyrinthine Schwannomas." In Abstract- und Posterband – 89. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Forschung heute – Zukunft morgen. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1640517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Venugopalan, Vasan. "Biotransport in Optical Diagnostics, Imaging, and Therapy." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192840.

Full text
Abstract:
Non-invasive characterization and manipulation of tissue structure and function across spatial scales is one of the most challenging problems facing the use of optical techniques in biomedicine. A broad technical goal for the use of optical methods is the non-invasive measurement and/or manipulation of tissue structure and function on the microscopic scale while preserving the ability to interrogate the largest possible tissue volume. This overall goal has resulted in a plethora of optical diagnostic, imaging, and therapeutic methodologies that utilize specific light-tissue interactions and exploit various endogenous and/or exogenous optical contrast elements.
APA, Harvard, Vancouver, ISO, and other styles
3

Zajac, Andrzej S. "Laser sources for medical diagnostics and therapy." In SPIE Proceedings, edited by Zbigniew Jaroszewicz, Ewa Powichrowska, and Mariusz Szyjer. SPIE, 2004. http://dx.doi.org/10.1117/12.577118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jankiewicz, Zdzislaw, Andrzej Zajac, Marek Skorczakowski, Waldemar Zendzian, G. A. Skripko, and I. G. Tarazewicz. "Laser sources for HpD diagnostics and therapy." In Lasers in Medicine, edited by Tadeusz Kecik and Wlodzimierz Nowakowski. SPIE, 1996. http://dx.doi.org/10.1117/12.236810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sirotkina, Marina A., Elena B. Kiseleva, Ekaterina V. Gubarkova, Lev A. Matveev, Vladimir Y. Zaitsev, Alexander L. Matveyev, Marina V. Shirmanova, et al. "Multimodal OCT for complex assessment of tumors response to therapy." In Clinical and Preclinical Optical Diagnostics, edited by J. Quincy Brown and Ton G. van Leeuwen. SPIE, 2017. http://dx.doi.org/10.1117/12.2285170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cubeddu, Rinaldo, Cosimo D’Andrea, Antonio Pifferi, Paola Taroni, Alessandro Torricelli, Gianluca Valentini, and Gianfranco Canti. "Fluorescence monitoring during Photodynamic Therapy of experimental tumors with AlS2Pc." In Biomedical Optical Spectroscopy and Diagnostics. Washington, D.C.: OSA, 2000. http://dx.doi.org/10.1364/bosd.2000.md2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vakulovskaya, Elena G., Victor P. Letyagin, Loubov V. Umnova, Georgiu N. Vorozhcsov, and Victor Philinov. "Photodynamic therapy and fluorescent diagnostics of breast cancer." In Biomedical Optics 2004, edited by David Kessel. SPIE, 2004. http://dx.doi.org/10.1117/12.538107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Grinyuk, V. A. "Electropuncture diagnostics results interpretation at mm-wave therapy conducting." In Proceedings of 12th International Crimean Conference on Microwave and Telecommunication Technology (CriMICo'2002). IEEE, 2002. http://dx.doi.org/10.1109/crmico.2002.1137373.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shuming Nie. "Biomedical nanotechnology for molecular imaging, diagnostics, and targeted therapy." In 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2009. http://dx.doi.org/10.1109/iembs.2009.5332688.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pešek, Miloš, Lucie Zdrhova, Radka Bittenglova, Terezie Turkova-Sedlackova, Karel Balihar, and Peter W. Dettmar. "Extraesophageal reflux (EER)—diagnostics and therapy in respiratory patients." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa740.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Biocybernetic diagnostics and therapy"

1

Kim, Jae G. Respiratory Challenges in Breast Cancer: Potential for Enhanced Diagnostics and Therapy. Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada542555.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Biocybernetic diagnostics and therapy' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography